25I-NBF

25I-NBF is a derivative of the phenethylamine hallucinogen 2C-I, which is used for its psychedelic effects. It is part of the 25x-NBx family and was first synthesized by the research team led by David E. Nichols at Purdue University.

History

25I-NBF was first synthesized by a research team at Purdue University led by David E. Nichols. It is part of the 25x-NBx family of psychedelic phenethylamines, specifically a derivative of 2C-I.

Chemistry

25I-NBF is a phenethylamine derivative and shares a common structure with other members of the 25x-NBx family. It is characterized by the substitution of an iodine atom at the 4 position of the phenyl ring.

Pharmacology

The pharmacology of 25I-NBF is not fully understood. It is known to act as a highly potent partial agonist for the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects.

Effects

The effects of 25I-NBF are similar to those of other psychedelic phenethylamines. These can include open and closed eye visuals, euphoria, time distortion, and introspection. As with all psychedelics, the effects are highly subjective and can vary greatly between individuals.

Legal Status

The legal status of 25I-NBF varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class A drug.

See Also

• 25I-NBOMe
• 25C-NBOMe
• 25B-NBOMe
• 2C-I
• Psychedelic phenethylamine

References

25I-NBF Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski